Much Controversial Gardasil Vaccine For Cervical Cancer Raises Doubts


March 9, 2010

New Zealand

Gardasil HPV vaccine for girls is revealed to be at least 16 times more likely to have a serious adverse affect to it, than to develop terminal cervical cancer, which according to critics raises doubts regarding the much controversial vaccine.

The doubt that millions of parents develop as television ads push for girls to receive Gardasil, a vaccine that is advertised to prevent infection from four types of human papillomavirus (HPV), the most common sexually transmitted virus in the United States. HPV is revealed to be the major culprit behindcervical cancer and genital warts.

As per the information released under the Official Information Act, the death rate for cervical cancer between 2002 and 2005 is registered to touch 1.95 deaths per 100,000 women.

This severely contrasts with 31 serious adverse affects for the 90,000 girls who received Gardasil vaccine so far.

It is recommended to seek medical attention if one notices any unusual conditions after the vaccination, such as a high fever or behavior changes, serious allergic reaction like difficulty in breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heartbeat or dizziness.



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.